Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutic company, develops drugs to treat diseases caused by protein or gene dysfunction. The company is headquartered in Lexington, Massachusetts.
Thursday's top analyst upgrades and downgrades included Agilent Technologies, Carnival, Clorox, Darden Restaurants, Pinduoduo, QuantumScape, Royal Dutch Shell and Williams-Sonoma.
Monday's top analyst upgrades and downgrades included American Express, AT&T, CRISPR Therapeutics, DocuSign, ONEOK, Regeneron Pharmaceuticals, Shopify and Tesla.
Sanofi and Translate Bio are making waves in the fight against the novel coronavirus as the two have agreed to expand their existing 2018 collaboration and license agreement
